Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers divulge SERDs for ER-positive breast cancer

May 17, 2018

Idenix Pharmaceuticals and Merck identify HIV-1 inhibitors

May 17, 2018

Bayer and collaborators present DHODH inhibitors

May 17, 2018

Boehringer Ingelheim discloses FFAR1 agonists

May 17, 2018

Bayer patents new vasopressin V1A and V2 receptor antagonists

May 17, 2018

Novo Nordisk expands chronic disease focus beyond type 1 diabetes

May 17, 2018

Eleven Biotherapeutics changes name to Sesen Bio

May 17, 2018

European Commission approves Cabometyx for first-line treatment of advanced RCC

May 17, 2018

IDMC recommends continuation of enrollment in phase IIa study of milciclib in HCC

May 17, 2018

Eiger Biopharmaceuticals obtains rights to lonafarnib for Hutchinson-Gilford progeria syndrome

May 17, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...